Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Drugmaker Teva to cut 14,000 jobs globally Teva Pharmaceutical Industries said it will lay off 14,000 jobs globally as part of a two-year restructuring plan, aimed at boosting its business and financial performance. Production & Manufacturing > Manufacturing > News
Asklepios BioPharmaceutical launches new portfolio company Actus Therapeutics Asklepios BioPharmaceutical has formed Actus Therapeutics, a new portfolio company based on AskBio’s industry-leading gene therapy platform.
Drug Research > Drug Discovery & Development > News FDA approves Pfizer’s Xeljanz and Xeljanz XR to treat active psoriatic arthritis The US Food and Drug Administration (FDA) has approved Pfizer’s Xeljanz 5 mg twice daily (BID) and Xeljanz XR (tofacitinib) extended release 11 mg once daily (QD) for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
News Drugmaker Teva to cut 14,000 jobs globally By PBR Staff Writer
Teva Pharmaceutical Industries said it will lay off 14,000 jobs globally as part of a two-year restructuring plan, aimed at boosting its business and financial performance.
Production & Manufacturing > Manufacturing > News
Flexion Therapeutics to acquire novel and non-opioid asset for osteoarthritis of knee Flexion Therapeutics has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203.
Production & Manufacturing > Manufacturing > News GW Pharmaceuticals reacquires full rights of develop Sativex in US GW Pharmaceuticals has terminated its previous license agreement with Otsuka Pharmaceutical in relation to Sativex (nabiximols) in the US.
Drug Research > Drug Discovery & Development > News Pfizer's biosimilar of J&J's Remicade secures FDA approval By PBR Staff Writer
Pfizer’s IXIFI (PF-06438179, infliximab-qbtx), a biosimilar to Johnson & Johnson’s rheumatoid arthritis drug Remicade (infliximab), has been approved by the US Food and Drug Administration (FDA) for all indications of the reference product.
News

Latest News and Insight by Sector

Production & Manufacturing

FDA approves Pfizer’s Xeljanz and Xeljanz XR to treat active psoriatic arthritis
The US Food and Drug Administration (FDA) has approved Pfizer’s Xeljanz 5 mg twice daily (BID) and Xeljanz XR (tofacitinib) extended release 11 mg once daily (QD) for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
News
Drugmaker Teva to cut 14,000 jobs globally
By PBR Staff Writer
Teva Pharmaceutical Industries said it will lay off 14,000 jobs globally as part of a two-year restructuring plan, aimed at boosting its business and financial performance.
Production & Manufacturing > Manufacturing > News

Drug Research

Asklepios BioPharmaceutical launches new portfolio company Actus Therapeutics
Asklepios BioPharmaceutical has formed Actus Therapeutics, a new portfolio company based on AskBio’s industry-leading gene therapy platform.
Drug Research > Drug Discovery & Development > News
GW Pharmaceuticals reacquires full rights of develop Sativex in US
GW Pharmaceuticals has terminated its previous license agreement with Otsuka Pharmaceutical in relation to Sativex (nabiximols) in the US.
Drug Research > Drug Discovery & Development > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

Combination of AbbVie's venetoclax and Rituxan succeeds in phase 3 R/R CLL trial
By PBR Staff Writer
AbbVie and Roche’s Venclexta/Venclyxto (venetoclax) in combination with MabThera/Rituxan (rituximab) succeeded in a phase 3 trial in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) by meeting the primary endpoint.
Contract Research & Services > Clinical Trials > News
NIH to provide funding for Alzheimer's advance clinical trials
By PBR Staff Writer
US-based National Institutes of Health (NIH) is set to provide financial assistance to a new clinical trials consortium to enhance studies for therapies in Alzheimer’s disease and related dementias.
Contract Research & Services > Clinical Trials > News

Automation

Recursion Pharmaceuticals uses Splunk machine learning to treat genetic diseases
Biotechnology company Recursion Pharmaceuticals is using Splunk Enterprise and the Splunk Machine Learning Toolkit to reach its target of treating 100 molecular genetic diseases by 2025.
Automation > IT & Software > News
Broad Institute of MIT and Harvard joins discussions to create global CRISPR-Cas9 licensing pool
The Broad Institute of MIT and Harvard has joined discussions to form a non-exclusive CRISPR-Cas9 joint licensing pool coordinated by MPEG LA, an organization that operates patent pool licensing programs in various institutions and countries.
Automation > IT & Software > News

Regulatory Affairs

Shire gets EC nod for lyophilized Oncaspar to treat acute lymphoblastic leukemia
By PBR Staff Writer
Shire has secured marketing approval from the European Commission (EC) for new formulation of Oncaspar to treat patients with acute lymphoblastic leukemia (ALL).
News
Sanofi’s Admelog (insulin lispro injection) gets FDA approval to treat diabetes
By PBR Staff Writer
Sanofi’s Admelog (insulin lispro injection) has been approved by the US Food and Drug Administration (FDA) to help diabetic patients control their blood sugar levels at mealtime.
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery